Latest Exploration News

Tanami Gold NL reported significant drilling progress at its Central Tanami Project with promising gold intercepts at Jims Gold Mine, while Mount Gibson Iron moves to acquire a 50% stake in the joint venture.

Element 25 Limited has locked in AU$50 million in senior debt from the Northern Australia Infrastructure Facility to expand its Butcherbird manganese project, while advancing its US battery-grade manganese refinery with significant government grants and patent protections.

Infini Resources has refined its geological model at the Portland Creek uranium project, identifying new high-priority targets for an August 2025 Phase 2 drilling campaign. Despite challenges in Phase 1, the company remains optimistic about unlocking a major discovery in Newfoundland.

Dateline Resources advances its Colosseum Gold-REE Project with a robust feasibility study, expanded exploration, and strong US government support, positioning itself as a key player in critical minerals.

Flynn Gold’s latest diamond drilling at the Trafalgar Prospect within its Golden Ridge Project reveals multiple high-grade gold veins, reinforcing the prospect’s geological model and potential scale. The company plans further drilling to refine resource estimates.

Vital Metals Limited has released a comprehensive Scoping Study for its Tardiff Rare Earths deposit in Canada, revealing strong economic potential with an 11-year mine life and significant neodymium-praseodymium resources.

BPH Global confirms that the seaweed Sesuvium portulacastrum accumulates valuable metals including gold and lithium, but shifts focus to biological extraction after chemical methods fall short.

White Cliff Minerals confirms significant high-grade copper and silver mineralisation at its Danvers prospect, raising A$14.4 million to fund expanded exploration. The company also announces a strategic board appointment as it advances its Rae Copper and Great Bear projects.

Titan Minerals reports strong drilling results at its Dynasty Gold and Linderos Copper projects, confirming significant mineralisation extensions and advancing joint venture milestones.

Cynata Therapeutics is advancing three pivotal clinical trials targeting acute Graft versus Host Disease, osteoarthritis, and kidney transplantation, with major results expected through early 2026. The company maintains a solid cash position supporting its clinical pipeline and strategic growth.

Bowen Coking Coal has appointed voluntary administrators after failing to secure fresh capital or negotiate with key creditors, reflecting mounting challenges in Queensland's coal sector. The administration aims to enable a sale or recapitalisation while maintaining operations at its Burton Mine Complex.

Westar Resources’ June quarter report reveals intriguing molybdenum, bismuth, and tungsten anomalies at its Mageye prospect, prompting a strategic review of exploration plans amid a solid $1.2 million cash position.